Mazdutide for adults with prediabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a once-weekly injection called mazdutide to help adults with prediabetes and higher weight lower their blood sugar and potentially lose weight. It is a double-blind, placebo-controlled trial, meaning some people get the real drug and some get a placebo (no active drug).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have prediabetes (blood sugar higher than normal but not yet diabetes) and a BMI of 22 or higher.
- Your weight has been stable (not changed by more than 10%) in the last 3 months, and you are not in a weight-loss program.
- You have not taken any diabetes medication or weight-loss prescription drugs in the last 3 months.
- You have no serious heart, pancreas, or stomach issues, and no history of certain types of thyroid cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication (mazdutide) to see if it can help people with type 2 diabetes achieve remission (normal blood sugar levels without needing diabetes medications). It is for adults with type 2 diabetes who are not well controlled on their current treatment (which can be diet and exercise alone, or metformin or an SGLT2 inhibitor). The study will last for a period of time, and participants will receive either the study drug or a placebo (inactive substance).
This trial tests whether combining lifestyle changes (diet and exercise) with a medication called mazdutide can help adults with obesity lose weight and keep it off. Mazdutide is an injectable medication that may help reduce appetite and support weight management over 2 years.
This trial tests a new once-weekly injection called Mazdutide for people with type 2 diabetes and moderate-to-severe fatty liver who are already taking semaglutide. The goal is to see if it can improve fatty liver and blood sugar control.
This study tests a new medication called mazdutide to see if it can reduce plaque buildup in the heart arteries of people who are overweight and have a moderate narrowing. If you qualify, you may receive the drug or a placebo and will be monitored over time.
This trial is testing a new medication called Mazdutide to help treat PCOS in women with obesity. It aims to see if it improves PCOS symptoms and related health issues.
This study tests a new injected medicine that may help people with type 2 diabetes and overweight or obesity lose weight. The trial will see how well it works and if it is safe compared to a placebo.
Hear when a new Prediabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.